RxDoctor Payments Data

Amy Boles, MD

Family Medicine · Mankato, MNNPI 1760473722

Payments from drug & device makers

$242in general payments, 2019–2025

Across 17 payments — averaging $14.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ironwood Pharmaceuticals, Inc$35
  • Biogen$33
  • Dexcom, Inc.$26
  • Boehringer Ingelheim$24
  • AstraZeneca$24
  • Si-bone, Inc.$18
  • plus $83 from 6 others

What the payments were for

  • Food & beverage$242100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$242 in reported general payments places this provider in the 80th percentile of 1,162 family medicine providers in Minnesota.

See all family medicine providers in Minnesota

Medicare billing

Part B allowed, 2024
$71,894
Medicare patients
287
Services billed
1,127

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban332$98,027
OzempicSemaglutide30$30,683
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog69$30,453
XareltoRivaroxaban123$27,394
RytaryCarbidopa/Levodopa26$19,198
Budesonide50$13,497
JardianceEmpagliflozin41$11,902
Atorvastatin Calcium629$10,255
ArexvyRsvpref3 Antigen/As01e/Pf33$10,148
Incruse ElliptaUmeclidinium Bromide25$9,457
MyrbetriqMirabegron39$9,291
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$9,085
Spiriva RespimatTiotropium Bromide19$8,787
Gabapentin552$8,556
EntrestoSacubitril/Valsartan21$7,883

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Spiriva Respimat, Combivent Respimat$24$28,47875 claims
Johnson & JohnsonXarelto$16$27,394123 claims
NovartisEntresto$15$7,88321 claims
AbbVieCreon$15$4,22413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,162 family medicine providers in Minnesota.

Other family medicine in Mankato

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →